FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076645244> ?p ?o ?g. }

• W2076645244 endingPage "388" @default.
• W2076645244 startingPage "383" @default.
• W2076645244 abstract "This study was conducted to evaluate the safety and efficacy of intravenous adenosine therapy for prehospital treatment of narrow-complex tachycardias with a presumptive field diagnosis of paroxysmal supraventricular tachycardia (PSVT) by paramedics without direct physician control. A ten-month prospective case series was designed in an urban EMS system that has paramedics operating under standing orders before physician radio contact. All patients with PSVT field diagnosis were included. Diagnosis of PSVT was made by regular, narrow-complex tachycardia with a heart rate greater than 160 beats/min by field ECG. Interpretation was performed solely by paramedics; ECG transmission was not available. In hemodynamically stable patients, vagal maneuvers were followed by intravenous placement and administration of adenosine as recommended by the manufacturer. If three adenosine boluses failed to convert the arrhythmia, patients were monitored and transported, with electrical cardioversion available. Data collection included demographics, history, medications, vital signs, and ECG tracings. Of 41 included patients, 31 were correctly diagnosed with PSVT (75.6%), with mean ventricular rate of 205 beats/min (SD 7 beats/min); one had sinus tachycardia; nine had atrial fibrillation (AF) (22%). Of the 31 cases correctly diagnosed as PSVT, 28 converted to sinus rhythm after adenosine (90.3%). Of those converted, 16 required a single dose (57.1%), nine required one additional dose (32.1%), and three required two additional doses (10.8%). None reverted to PSVT after adenosine conversion during the study period (conversion to arrival at emergency department). No significant difference in length of asystolic pause or in outcome was detected between the true PSVT cases and the AF cases receiving adenosine. There were no significant deleterious side effects in the adenosine group. It was concluded that adenosine is effective for prehospital treatment of narrow-complex tachycardias, and its safety profile appears to allow paramedic administration without “requisite” physician control. It should be used as directed by the manufacturer and may prove to be a valuable prehospital diagnostic adjunct in AF and hemodynamically stable abberant PSVT masked as wide-complex tachycardia." @default.
• W2076645244 created "2016-06-24" @default.
• W2076645244 creator A5035535084 @default.
• W2076645244 creator A5038141990 @default.
• W2076645244 creator A5040472838 @default.
• W2076645244 creator A5045080831 @default.
• W2076645244 creator A5056308913 @default.
• W2076645244 creator A5088393212 @default.
• W2076645244 date "1995-07-01" @default.
• W2076645244 modified "2023-09-27" @default.
• W2076645244 title "Intravenous adenosine as first-line prehospital management of narrow-complex tachycardias by EMS personnel without direct physician control" @default.
• W2076645244 cites W1968434274 @default.
• W2076645244 cites W1974433402 @default.
• W2076645244 cites W1986899366 @default.
• W2076645244 cites W2011375554 @default.
• W2076645244 cites W2013223130 @default.
• W2076645244 cites W2038607970 @default.
• W2076645244 cites W2042411460 @default.
• W2076645244 cites W2050641639 @default.
• W2076645244 cites W2077123070 @default.
• W2076645244 cites W2084939907 @default.
• W2076645244 cites W2086637755 @default.
• W2076645244 cites W2127856270 @default.
• W2076645244 cites W2144793172 @default.
• W2076645244 cites W2150867579 @default.
• W2076645244 cites W4245570718 @default.
• W2076645244 doi "https://doi.org/10.1016/0735-6757(95)90119-1" @default.
• W2076645244 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7605518" @default.
• W2076645244 hasPublicationYear "1995" @default.
• W2076645244 type Work @default.
• W2076645244 sameAs 2076645244 @default.
• W2076645244 citedByCount "34" @default.
• W2076645244 countsByYear W20766452442013 @default.
• W2076645244 countsByYear W20766452442014 @default.
• W2076645244 countsByYear W20766452442015 @default.
• W2076645244 countsByYear W20766452442016 @default.
• W2076645244 countsByYear W20766452442017 @default.
• W2076645244 countsByYear W20766452442020 @default.
• W2076645244 countsByYear W20766452442022 @default.
• W2076645244 countsByYear W20766452442023 @default.
• W2076645244 crossrefType "journal-article" @default.
• W2076645244 hasAuthorship W2076645244A5035535084 @default.
• W2076645244 hasAuthorship W2076645244A5038141990 @default.
• W2076645244 hasAuthorship W2076645244A5040472838 @default.
• W2076645244 hasAuthorship W2076645244A5045080831 @default.
• W2076645244 hasAuthorship W2076645244A5056308913 @default.
• W2076645244 hasAuthorship W2076645244A5088393212 @default.
• W2076645244 hasBestOaLocation W20766452441 @default.
• W2076645244 hasConcept C118552586 @default.
• W2076645244 hasConcept C126322002 @default.
• W2076645244 hasConcept C164705383 @default.
• W2076645244 hasConcept C188816634 @default.
• W2076645244 hasConcept C194828623 @default.
• W2076645244 hasConcept C2775914520 @default.
• W2076645244 hasConcept C2776331378 @default.
• W2076645244 hasConcept C2776934708 @default.
• W2076645244 hasConcept C2777289489 @default.
• W2076645244 hasConcept C2777953023 @default.
• W2076645244 hasConcept C2779161974 @default.
• W2076645244 hasConcept C2780040984 @default.
• W2076645244 hasConcept C2780144208 @default.
• W2076645244 hasConcept C2780283014 @default.
• W2076645244 hasConcept C2780724011 @default.
• W2076645244 hasConcept C42219234 @default.
• W2076645244 hasConcept C71924100 @default.
• W2076645244 hasConcept C84393581 @default.
• W2076645244 hasConceptScore W2076645244C118552586 @default.
• W2076645244 hasConceptScore W2076645244C126322002 @default.
• W2076645244 hasConceptScore W2076645244C164705383 @default.
• W2076645244 hasConceptScore W2076645244C188816634 @default.
• W2076645244 hasConceptScore W2076645244C194828623 @default.
• W2076645244 hasConceptScore W2076645244C2775914520 @default.
• W2076645244 hasConceptScore W2076645244C2776331378 @default.
• W2076645244 hasConceptScore W2076645244C2776934708 @default.
• W2076645244 hasConceptScore W2076645244C2777289489 @default.
• W2076645244 hasConceptScore W2076645244C2777953023 @default.
• W2076645244 hasConceptScore W2076645244C2779161974 @default.
• W2076645244 hasConceptScore W2076645244C2780040984 @default.
• W2076645244 hasConceptScore W2076645244C2780144208 @default.
• W2076645244 hasConceptScore W2076645244C2780283014 @default.
• W2076645244 hasConceptScore W2076645244C2780724011 @default.
• W2076645244 hasConceptScore W2076645244C42219234 @default.
• W2076645244 hasConceptScore W2076645244C71924100 @default.
• W2076645244 hasConceptScore W2076645244C84393581 @default.
• W2076645244 hasIssue "4" @default.
• W2076645244 hasLocation W20766452441 @default.
• W2076645244 hasLocation W20766452442 @default.
• W2076645244 hasOpenAccess W2076645244 @default.
• W2076645244 hasPrimaryLocation W20766452441 @default.
• W2076645244 hasRelatedWork W1972651039 @default.
• W2076645244 hasRelatedWork W2117709805 @default.
• W2076645244 hasRelatedWork W2137380071 @default.
• W2076645244 hasRelatedWork W2140392144 @default.
• W2076645244 hasRelatedWork W2148295115 @default.
• W2076645244 hasRelatedWork W2185505634 @default.
• W2076645244 hasRelatedWork W2202497401 @default.
• W2076645244 hasRelatedWork W2317055961 @default.
• W2076645244 hasRelatedWork W2791438477 @default.

• next